EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES

东部肿瘤合作组 - 威斯康星州研究

• 批准号: 7869601
• 负责人: Brad Kahl
• 金额: $ 61.48万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 2016-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7869601
• 关键词: Affect; Cancer Burden; Categories; Clinical; Clinical Research; Clinical Trials; Commit; Comprehensive Cancer Center; Data Quality; Early Diagnosis; Eastern Cooperative Oncology Group; Evaluation; Faculty; Grant; Human; Individual; Institution; Leadership; Malignant Neoplasms; Outcome; Participant; Patients; Population; Prevention; Research; System; Translations; Universities; War; Wisconsin; cancer care; cancer therapy; design; improved; programs

DESCRIPTION (provided by applicant): This application seeks support for the activities of the Eastern Cooperative Oncology Group (ECOG) at the UW Paul P. Carbone Comprehensive Cancer Center (UWCCC). Over the past 30 years, the UWCCC has maintained exemplary main institution accrual and strong affiliate participation while providing high quality data and key scientific leadership. Institutional evaluations consistently rank the UW ECOG program at or near the top in categories of accrual, administrative, and scientific leadership. The basic, translational, and clinical research programs of the UWCCC are designed to reduce the cancer burden on the population by improving prevention, early detection, and treatment of cancer. The UWCCC commitment to cancer care and research has never been stronger. During the current grant cycle, we have tripled our clinical space and doubled our research space, representing an institutional commitment of nearly $100 million, and increased our cancer focused faculty by nearly 50%. The UWCCC faculty views the NCI cooperative groups as essential components in the war on cancer. Translation of scientific discovery to human populations and to individual patients requires an ability to conduct large scale clinical trials in a timely fashion. ECOG provides this vital forum and the UWCCC remains highly committed to its mutually beneficial partnership with ECOG. RELEVANCE: ECOG clinical trials are a vitally important cancer treatment option for the citizens of Wisconsin. Group trials represent a proven system for improving outcomes for patients affected by cancer and the University of Wisconsin and its ECOG affiliates remain enthusiastic participants in the cooperative group system.

描述（由申请人提供）：本申请寻求支持在UW Paul P. Carbone综合癌症中心（UWCCC）的东部合作肿瘤学集团（ECOG）的活动。在过去的30年中，UWCCC在提供高质量的数据和关键的科学领导力的同时，保持了典范的主要机构应计和强大的会员参与。机构评估始终在应计，行政和科学领导类别的类别中或顶部将UW ECOG计划排名或附近。 UWCCC的基本，翻译和临床研究计划旨在通过改善预防，早期发现和治疗癌症来减轻人群的癌症负担。 UWCCC对癌症护理和研究的承诺从未如此强大。在当前的赠款周期中，我们将临床空间增加了两倍，并使研究空间增加了一倍，代表了近1亿美元的机构承诺，并将以癌症为中心的教师提高了近50％。 UWCCC教师认为NCI合作团体是癌症战争的重要组成部分。将科学发现向人群和个别患者的转换需要及时进行大规模临床试验的能力。 ECOG提供了这个重要的论坛，UWCCC仍然致力于与ECOG的互惠互利伙伴关系。 相关性：ECOG临床试验是威斯康星州公民的至关重要的癌症治疗选择。小组试验代表了一种可靠的系统，用于改善受癌症影响的患者和威斯康星大学及其ECOG分支机构的结局，仍然是合作团体系统中的热情参与者。